基于后生物的功能性食品作为食物过敏治疗方法
Nader Khani1, Faezeh Shirkhan2, Mansour Rabie Ashkezary3
1Student Research Committee, Tabriz University of Medical Sciences, Tabriz 5166614766, Iran.
Foods (Basel, Switzerland)
|October 29, 2025
概括
功能性食品,特别是那些富含开后生物质的发酵食品,如和酸奶,显示出对食物过敏 (FA) 的管理有前途. 这些食物提供了一种安全,经济有效的方法来支持免疫耐受性,并打击FA的流行率上升.
科学领域:
- 营养科学 营养科学
- 免疫学 免疫学 免疫学
- 食品科学 食品科学 食品科学
背景情况:
- 在过去的二十年中,食物过敏 (FA) 的患病率和严重程度显著增加.
- FA是由身体免疫耐受性的崩引起的.
- 功能性食品越来越多地被认为具有超出基本营养的健康益处.
研究的目的:
- 审查功能性食品的潜力,特别是基于后生物质的功能性食品,以控制食物过敏.
- 探索如何发酵食品可以作为FA的治疗策略.
主要方法:
- 这项研究是对功能性食品和食物过敏现有文献的综述.
- 它专注于从发酵食品中提取的后生物质,如,酸奶,奶酪和发酵牛奶.
- 该审查审查了这些食物可能影响免疫耐受性的机制.
主要成果:
- 功能性食品为包括FA在内的健康管理提供了具有成本效益和安全的替代方案.
- 富含后生物质的发酵食品显示出FA的潜在治疗特性.
- 定期食用这些功能性食物可能有助于恢复免疫耐受性.
结论:
- 功能性食品,特别是含有后生物质的发酵食品,是预防和治疗食物过敏的有希望的途径.
- 对后生物丰富的功能性食品的进一步研究可能会导致管理FA的新策略.
- 这些食物可以整合到饮食方法中,以支持免疫健康和对抗过敏的发展.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
631
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
631
Microorganisms in Medicine and Therapeutics
928
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
928
Taste Buds and Receptors
4.6K
Gustation, or the sense of taste, is intrinsically linked to the anatomical structures located on the tongue. This organ's surface, along with the entirety of the oral cavity, is adorned with stratified squamous epithelium. Evident on the tongue are elevated structures known as papillae (singular = papilla), which house the mechanisms for the transduction of gustatory stimuli. Four distinct types of papillae exist, each identified by their unique morphological attributes: the circumvallate,...
4.6K
Drugs for Treatment of Constipation-Predominant IBS
698
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
698
Biological Methods for Microbial Control
776
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
776
Drugs for Treatment of Diarrhea-Predominant IBS
618
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
618


